ABBOTT LABORATORIES holding history
As of Nov. 6, 2026 (UTC)
| March 31, 2025 | 70,487 | $9,350,042 | 0.03% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 9, 2025 |
| June 30, 2025 | 47,284 | $6,431,080 | 0.02% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | July 29, 2025 |
| Sept. 30, 2025 | 46,827 | $6,271,974 | 0.02% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Nov. 12, 2025 |
| Dec. 31, 2025 | 45,135 | $5,654,917 | 0.02% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Feb. 9, 2026 |
| March 31, 2026 | 38,613 | $3,964,375 | 0.01% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 8, 2026 |
| June 30, 2026 | Absent this quarter | — | — | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 12, 2026 |
6 rows · Sort by column; scroll horizontally for more.
No rows match these filters.
Schedule 13G disclosures
No verified related disclosures are included in this freeze.
About reported holdings
13F reports quarter-end securities, excluding cash and shorts. Position changes do not establish trades, motives or returns; portfolio weights use disclosed 13F value.